Answers are grounded in this paper and cite their sources.
Background Dysfunctional breathing is increasingly recognised among individuals with post-COVID-19 condition (PCC), yet data on long-term prevalence and predictors are scarce. This study assessed the prevalence of symptoms suggestive of dysfunctional breathing, as indicated by elevated Nijmegen questionnaire (NQ) scores, four years after COVID-19 illness in adults with PCC and identified associated factors and baseline predictors by comparing individuals with and without elevated NQ scores. Method In this prospective observational study, adults with PCC, both previously hospitalised and non-hospitalised for COVID-19, were recruited from a specialised post-COVID outpatient clinic. Baseline assessments (2020–2022) were analysed together with data from a digital follow-up survey in 2024. Symptoms suggestive of dysfunctional breathing was defined as a NQ score ≥ 23 at follow-up. Between group differences were examined, and multivariable logistic regression models were used to identify associated factors and baseline predictors. Results Among 288 participants (median follow-up 50 months), 143 (50%) had symptoms suggestive of dysfunctional breathing. These individuals were younger, often female, and more frequently non-hospitalised during acute COVID-19. Baseline predictors included non-hospitalisation, higher dyspnoea severity, lower FEV1, and younger age. At four years, elevated NQ scores (≥ 23) were independently associated with higher dyspnoea severity, greater PCC-symptom burden, depressive symptoms and postural orthostatic tachycardia syndrome. Individuals with symptoms suggestive of dysfunctional breathing performed worse in the six-minute walk test, one-minute sit to stand test, and maximal inspiratory pressure test at baseline, whereas lung function did not differ. Patient-reported outcomes were consistently worse compared with those with NQ scores < 23 and improved less over time. Conclusion Half of the individuals with PCC in this cohort reported symptoms suggestive of dysfunctional breathing four years after COVID-19, as indicated by a NQ score ≥ 23. Elevated NQ scores were associated with greater PCC-symptom burden and poorer health outcomes, highlighting their potential clinical relevance in long-term PCC. Future studies should combine patient-reported measures with objective assessment of breathing pattern and ventilatory function.
No takes yet. Share an insight, caveat, or question.
Hallberg et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: